Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MA › Roslindale › NPI 1386718823
Clinic

Boston Medical Center Corporation

Boston Medical Center Corporation was paid $9.88M by Medicaid between Jan 2018 and Dec 2024, across 243 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 30% of everything it billed.

33Billing provider infoBOSTON MEDICAL CENTER CORPORATION
ROSLINDALE, MA 02131
33aNPI1386718823assigned 11/17/2006
33bProvider typeCommunity Health Clinic/Center
28Total paid$9.88M
24GClaims268,793
24DCodes billed243
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Community Health Clinic/Center providers in Massachusetts

Rank by total paid#15 of 36
Median peer was paid$3.62M
This provider vs. median2.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201828,859$1.04M
201925,008$977K
202041,121$1.97M
202140,670$1.76M
202243,616$2.21M
202346,325$1.18M
2024incomplete43,194$750K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 30% 48,024 43,626 $2.97M
T1015 A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive 13% 8,160 7,582 $1.25M
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 12% 16,705 15,532 $1.19M
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 2.4% 2,598 2,593 $233K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 2.0% 2,228 2,221 $201K
D9450 1.8% 16,814 9,973 $176K
D1110 Prophylaxis - adult 1.7% 5,384 4,040 $167K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 1.6% 1,491 1,393 $157K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 1.5% 1,456 1,344 $146K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 1.4% 6,897 5,676 $143K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 1.4% 1,649 1,642 $136K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 1.4% 1,759 1,756 $135K
231 more codes
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 1.3% 12,207 $133K
99215 Doctor's office visit, returning patient (complex) 1.2% 1,060 $123K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 1.2% 4,334 $115K
90834 Psychotherapy session, about 45 minutes 1.1% 1,317 $113K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years 1.1% 1,384 $111K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 1.1% 4,254 $109K
99203 Doctor's office visit, new patient (routine) <1% 969 $88K
87481 <1% 1,419 $84K
99283 Emergency room visit (moderate) <1% 473 $81K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r <1% 1,139 $75K
D0120 Dental checkup, returning patient <1% 4,482 $70K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 4,024 $65K
D2392 Resin-based composite - two surfaces, posterior, primary or permanent <1% 1,178 $61K
99285 Emergency room visit (most serious) <1% 301 $56K
D0274 Bitewings - four radiographic images <1% 2,261 $55K
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 4,475 $55K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 1,935 $50K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 1,702 $49K
99188 <1% 1,808 $47K
D1120 Dental cleaning, child <1% 1,028 $44K
96361 Intravenous infusion, hydration; each additional hour <1% 122 $44K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 329 $44K
D0210 Intraoral - complete series of radiographic images <1% 1,145 $44K
87511 <1% 1,421 $43K
D1206 Topical application of fluoride varnish <1% 1,613 $41K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 283 $39K
99284 Emergency room visit (serious) <1% 244 $38K
83036 Hemoglobin; glycosylated (A1C) <1% 7,473 $37K
D0150 Comprehensive oral evaluation - new or established patient <1% 1,397 $36K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 802 $34K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 285 $34K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 1,497 $34K
D2391 Resin-based composite - one surface, posterior, primary or permanent <1% 713 $33K
86780 <1% 3,208 $31K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 1,232 $30K
86480 <1% 604 $28K
80050 General health panel <1% 2,084 $26K
84443 Thyroid stimulating hormone (TSH) <1% 3,160 $25K
86803 <1% 2,583 $25K
90715 <1% 1,258 $24K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 171 $23K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,152 $23K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 5,291 $22K
90472 Immunization administration, each additional vaccine (list separately) <1% 4,084 $22K
D9110 <1% 860 $22K
90651 <1% 1,020 $20K
80061 Lipid panel <1% 6,164 $19K
99204 Doctor's office visit, new patient (more involved) <1% 156 $19K
90670 <1% 703 $18K
0012A <1% 680 $18K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 110 $17K
91322 <1% 229 $16K
90686 <1% 2,373 $14K
0011A <1% 673 $14K
88142 <1% 784 $14K
90756 <1% 793 $13K
90480 <1% 305 $12K
90746 <1% 354 $12K
84703 <1% 1,816 $12K
92552 <1% 436 $11K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 341 $11K
90688 <1% 626 $11K
99173 <1% 1,175 $10K
90677 <1% 411 $10K
90833 Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) <1% 262 $10K
0001A <1% 215 $10K
0064A <1% 354 $9K
80048 Basic metabolic panel (calcium, ionized) <1% 3,246 $9K
0002A <1% 205 $9K
D0220 Intraoral - periapical first radiographic image <1% 965 $9K
87086 Culture, bacterial; quantitative colony count, urine <1% 1,453 $9K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) <1% 205 $8K
0004A <1% 191 $8K
92551 <1% 798 $8K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 17 $8K
87486 <1% 284 $7K
87581 <1% 284 $7K
82728 <1% 630 $7K
97161 <1% 27 $7K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 52 $6K
90661 <1% 650 $6K
83550 <1% 856 $6K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 428 $6K
80053 Comprehensive metabolic panel <1% 1,595 $6K
86706 <1% 691 $5K
0071A <1% 135 $5K
36415 Collection of venous blood by venipuncture <1% 8,852 $5K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 34 $5K
0072A <1% 112 $5K
0134A <1% 136 $5K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 103 $5K
86765 <1% 217 $5K
90716 <1% 164 $5K
82274 <1% 391 $4K
0124A <1% 107 $4K
90734 <1% 256 $4K
90832 Psychotherapy session, about 30 minutes <1% 59 $4K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 25 $3K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 50 $3K
90658 <1% 241 $3K
87340 <1% 428 $3K
86762 <1% 270 $3K
90707 <1% 181 $3K
86787 <1% 263 $3K
85018 <1% 1,273 $3K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 51 $3K
G0378 Hospital observation service, per hour <1% 24 $3K
86735 <1% 216 $2K
81003 <1% 1,359 $2K
81001 <1% 1,111 $2K
87081 <1% 386 $2K
82607 <1% 225 $2K
82043 <1% 867 $2K
J1050 Injection, medroxyprogesterone acetate, 1 mg <1% 39 $2K
82805 <1% 47 $2K
70355 <1% 31 $2K
71046 Radiologic examination, chest; 2 views <1% 143 $2K
99442 <1% 41 $2K
90791 Psychiatric diagnostic evaluation <1% 14 $2K
99385 <1% 45 $2K
90837 Psychotherapy session, about an hour <1% 14 $2K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 13 $2K
D0180 <1% 108 $2K
D1208 Topical application of fluoride, excluding varnish <1% 58 $2K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 492 $2K
85027 <1% 309 $2K
99382 <1% 12 $1K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 13 $1K
82746 <1% 147 $1K
90674 <1% 52 $1K
70450 Computed tomography, head or brain; without contrast material <1% 13 $1K
D2150 Silver amalgam - two surfaces, primary or permanent <1% 23 $1K
11719 <1% 154 $1K
D0140 Limited oral evaluation - problem focused <1% 33 $972.00
J3490 Unclassified drugs <1% 26 $958.44
84439 <1% 134 $954.10
90662 <1% 153 $884.22
84702 <1% 70 $851.88
91301 <1% 576 $774.90
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 51 $744.60
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 16 $716.28
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit <1% 162 $713.16
87536 <1% 18 $698.58
86850 <1% 132 $670.98
91300 <1% 315 $664.20
90633 <1% 329 $635.40
90694 <1% 67 $625.84
84484 <1% 84 $555.86
87522 Neg quan hep c or qual rna <1% 15 $546.98
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 102 $498.96
J3010 Injection, fentanyl citrate, 0.1 mg <1% 73 $498.96
J2704 Injection, propofol, 10 mg <1% 58 $498.96
83605 <1% 63 $468.00
G0008 Administration of influenza virus vaccine <1% 503 $460.15
G2012 Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion <1% 75 $454.35
86708 <1% 42 $448.13
86141 <1% 53 $436.97
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 16 $397.45
83690 <1% 81 $383.69
90732 <1% 25 $378.97
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 49 $374.22
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 37 $374.22
87430 <1% 32 $372.60
ATP03 <1% 232 $359.27
90619 <1% 206 $329.30
87641 <1% 16 $320.10
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 44 $311.85
83970 <1% 17 $301.20
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 13 $288.09
83735 <1% 103 $287.17
86753 <1% 25 $284.18
86900 <1% 132 $275.40
86901 <1% 132 $270.37
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 102 $250.52
90656 <1% 120 $244.71
87186 <1% 33 $228.52
91307 <1% 270 $221.40
85610 <1% 110 $214.80
83540 <1% 56 $213.67
73610 <1% 17 $181.60
83655 <1% 1,294 $164.42
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 13 $154.24
77067 Screening mammography, bilateral, including computer-aided detection <1% 13 $141.65
85652 <1% 70 $132.84
85730 <1% 29 $126.04
86580 <1% 13 $119.80
87077 <1% 15 $95.81
82570 <1% 37 $94.40
73630 <1% 16 $90.80
90653 <1% 31 $82.64
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 18 $79.28
80076 <1% 14 $66.03
82330 <1% 47 $64.64
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 17 $62.34
82465 <1% 13 $52.06
82248 <1% 65 $46.14
84156 <1% 20 $36.85
Q2038 Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) <1% 26 $34.91
82550 <1% 15 $32.61
84450 <1% 12 $29.58
82947 <1% 12 $29.58
84460 <1% 12 $29.56
82962 <1% 251 $21.78
82565 <1% 13 $16.39
T1013 Sign language or oral interpretive services, per 15 minutes <1% 13 $10.50
91313 <1% 94 $0.01
91306 <1% 256 $0.01
90648 0% 320 $0.00
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 0% 50 $0.00
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen 0% 15 $0.00
84100 0% 19 $0.00
91312 0% 83 $0.00
99218 0% 74 $0.00
91321 0% 45 $0.00
90681 0% 12 $0.00
90685 0% 16 $0.00
90710 0% 15 $0.00
90700 0% 17 $0.00
90697 0% 247 $0.00
71045 Radiologic examination, chest; single view 0% 14 $0.00
80320 0% 47 $0.00
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 0% 36 $0.00
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 0% 131 $0.00
90723 0% 154 $0.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 0% 77 $0.00
96375 Therapeutic injection; each additional sequential IV push 0% 88 $0.00
96376 0% 21 $0.00
36416 0% 33 $0.00
80329 0% 13 $0.00
90474 0% 17 $0.00
G0009 Administration of pneumococcal vaccine 0% 15 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialNEWSOM, TERESA (SVP, CFO)
Parent organizationBOSTON MEDICAL CENTER CORPORATION
Same official

Other billing entities under NEWSOM, TERESA

Full network →
ProviderLocationPaid
Greenville Health SystemSimpsonville, SC$29K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.